Document is current
Any future updates will be listed below
-
Authors
Buemi, Valentina
Schillaci, Odessa
Santorsola, Mariangela https://orcid.org/0000-0001-8514-932X
Bonazza, Deborah
Broccia, Pamela Veneziano
Zappone, Annie
Bottin, Cristina
Dell’Omo, Giulia
Kengne, Sylvie
Cacchione, Stefano https://orcid.org/0000-0002-7278-3695
Raffa, Grazia Daniela https://orcid.org/0000-0002-5072-5240
Piazza, Silvano
di Fagagna, Fabrizio d’Adda https://orcid.org/0000-0002-9603-5966
Benetti, Roberta https://orcid.org/0000-0001-8863-0821
Cortale, Maurizio
Zanconati, Fabrizio
Del Sal, Giannino https://orcid.org/0000-0003-2185-6003
Schoeftner, Stefan https://orcid.org/0000-0002-8918-6627
-
Funding
Funding for this research was provided by:
Agenzia Spaziale Italiana (2016-6-U0)
Fondazione Telethon (GPP13147)
Fondazione Telethon (GGP17111)
Associazione Italiana per la Ricerca sul Cancro (21091)
Associazione Italiana per la Ricerca sul Cancro (17756)
Associazione Italiana per la Ricerca sul Cancro (22759)
Associazione Italiana per la Ricerca sul Cancro (22174)
Associazione Italiana per la Ricerca sul Cancro (23074)
EC | European Regional Development Fund (ITAT1096-P)
EC | European Regional Development Fund (ITAT1050)
EC | European Regional Development Fund (ITAT1096-P)
EC | European Regional Development Fund (ITAT1050)
- License Information
-
More Information
Article History
Received: 9 November 2020
Accepted: 25 March 2022
First Online: 28 April 2022
Competing interests
: G:D.R, S.C, and S.S. are inventors on patent applications related to chemical inhibition of TGS1 in telomere diseases (“Pharmaceutical composition for the chemical inhibition of TGS1 as therapeutic treatment for telomeropathies”; PCT/IB2021/054484). Other authors declare no competing interest.
